Mutations in the Tet domain can result in oligomerization defects with possible clinical consequences, as demonstrated by certain missense pathogenic germline TP53 mutations identified in the Li-Fraumeni syndrome [8,20]. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.